A dramatic case of calciphylaxis 20 years after kidney transplantation

Nephrology Dialysis Transplantation

Volumn 19, Issue 12, 2004, Pages 3183-3185

  Vanbelleghem, Hilde ^a   Terryn, Wim ^a   Van Leuven, Leen ^b   Van Caesbroeck, Daniel ^c   Demetter, Pieter ^a   Lameire, Norbert ^a  

^a GHENT UNIVERSITY   (Belgium)

^b AZ St Josef   (Belgium)

^c Division of Pathology   (Belgium)

Author keywords

Calciphylaxis; Kidney transplantation; Secondary hyperparathyroidism

Indexed keywords

AZATHIOPRINE; CALCITRIOL; CALCIUM CARBONATE; CARBAMAZEPINE; CORTICOSTEROID; PARATHYROID HORMONE;

ADULT; ARTERY CALCIFICATION; ARTICLE; BRAIN CALCIFICATION; CASE REPORT; CHRONIC KIDNEY DISEASE; COMPUTER ASSISTED TOMOGRAPHY; ELECTROENCEPHALOGRAPHY; HEMODIALYSIS; HUMAN; HYPERCALCEMIA; HYPERPARATHYROIDISM; HYPOCALCEMIA; HYPOPHOSPHATEMIA; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; MULTIPLE ORGAN FAILURE; NEPHRECTOMY; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROIDECTOMY; PRIORITY JOURNAL; SEPSIS; URETHRA OBSTRUCTION;

ADULT; CALCIPHYLAXIS; FATAL OUTCOME; HUMANS; KIDNEY TRANSPLANTATION; MALE; TIME FACTORS;

EID: 11244300771     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfh442     Document Type: Article

References (10)

1. Basile C, Montanaro A, Masi M et al. Hyperbaric oxygen therapy for calcific uremic arteriolopathy: a case series. J Nephrol 2002; 15: 676-680
2. Fine A, Zacharias J. Calciphylaxis is usually non-ulcerating: risk factors, outcome and therapy. Kidney Int 2002; 61: 2210-2217
3. Hafner J, Keusch G, Wahl C et al. Uremic small-artery disease with medial calcification and intimal hyperplasia (so-called calciphylaxis): a complication of chronic renal failure and benefit from parathyroidectomy. J Am Acad Dermatol 1995; 33: 954-962
4. Smiley CM, Hanlon SU, Michel DM. Calciphylaxis in moderate renal insufficiency: changing disease concepts. Am J Nephrol 2000; 20: 324-328
5. Mirza I, Chaubay D, Gunderia H et al. An unusual presentation of calciphylaxis due to primary hyperparathyroidism. Arch Pathol Lab Med 2001; 125: 1351-1353
6. Mazhar AR, Johnson RJ, Gillen D. Risk factors and mortality associated with calciphylaxis in end-stage renal disease. Kidney Int 2001; 60: 324-332
7. Llach F. The evolving pattern of calciphylaxis: therapeutic considerations. Nephrol Dial Transplant 2001; 16: 448-451
8. Schafer C, Heiss A, Schwarz A et al. The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest 2003; 112: 357-366
9. Selye H, Gabbiani G, Strebel R. Sensitization to calciphylaxis by endogenous parathyroid hormone. Endocrinology 1962; 71: 554-558
10. Don BR, Chin AI. A strategy for the treatment of calcific uremic arteriolopathy (calciphylaxis) employing a combination of therapies. Clin Nephrol 2003; 59: 463-470